3E Bioventures Develops RNA & Protein Drug Separately
09 Jun 2026
US$ 20.00
3E Bioventures and Shanghai State-owned Capital Investment Co Ltd have co-led the angel+ financing round of ......
Related Publications
BGH Capital (BGH) joined the contest for ASX-listed EQT Holdings Ltd (EQTH), offering A$24.75 (US$17.7) per share, 0.8%...
TPG Inc has sold part of its stake in the India-listed Aster DM Quality Care Ltd (Aster QC) and clocked 44.5 bn rupees...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.